Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03881728
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
KCP | 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)- METHYL]-5-METHYL-3,6-DIHYDRO-2H- [1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVL | 0.78 |  |
PG1 | PENICILLIN G ACYL-SERINE | A,B | 1XA7 | 0.7 | |
| PG1 | PENICILLIN G ACYL-SERINE | A | 2IWC | 0.7 | |
| PG1 | PENICILLIN G ACYL-SERINE | A,B | 1MWT | 0.7 | |
BDK | 2-[5-AMINO-6-OXO-2-(2-THIENYL)- 1,6-DIHYDROPYRIMIDIN-1-YL)-N-[3,3- DIFLUORO -1-ISOPROPYL-2-OXO-3-(N- (2-MORPHOLINO ETHYL)CARBAMOYL]PROPYL]ACETAMIDE | A | 1EAU | 0.7 | |
CLS | CEPHALOTHIN | A,B | 1KVL | 0.75 | |
CTB | N-2-THIOPHEN-2-YL-ACETAMIDE BORONIC ACID | A,B | 1FSW | 0.7 | |
THN | 2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)- METHYL]-5-METHYLENE-5,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVL | 0.73 | |
NCF | (2R)-2-{(1R)-2-OXO-1-[(2-THIENYLACETYL)AMINO]ETHYL}- 5,6-DIHYDRO-2H-1,3-THIAZINE-4-CARBOXYLIC ACID | A,B,C,D | 1W8Y | 0.74 | |
895 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHENESULFONAMIDE | D,H | 2JH5 | 0.72 | |
| 895 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHENESULFONAMIDE | A | 2UWL | 0.72 | |
894 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHANESULFONAMIDE | A | 2UWP | 0.72 | |
| 894 | 2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}ETHANESULFONAMIDE | D,H | 2JH6 | 0.72 | |
CFX | CEFOXITIN | A,B | 1YMX | 0.72 | |
| CFX | CEFOXITIN | A,B | 1I2W | 0.72 | |
701 | (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}PROPENE-1-SULFONAMIDE | D,H | 2JH0 | 0.72 | |
| 701 | (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)- 1-[(1S)-1-METHYL-2-MORPHOLIN-4- YL-2-OXOETHYL]-2-OXOPYRROLIDIN- 3-YL}PROPENE-1-SULFONAMIDE | A | 2UWO | 0.72 | |
CS3 | S-[3-OXO-3-(2-THIENYL)PROPYL]-L- CYSTEINE | A | 2OQW | 0.71 | |
CEO | 5-METHYLENE-2-[2-OXO-1-(2-THIOPHEN- 2-YL-ACETYLAMINO)-ETHYL]-5,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A,B | 1KVM | 0.72 | |
CEP | CEPHALOTHIN GROUP | A | 1CEG | 0.76 | |
| CEP | CEPHALOTHIN GROUP | A | 1IYP | 0.76 | |
CED | 5-METHYL-2-[2-OXO-1-(2-THIOPHEN- 2-YL-ACETYLAMINO)-ETHYL]-3,6-DIHYDRO- 2H-[1,3]THIAZINE-4-CARBOXYLIC ACID | A | 1GHM | 0.77 | |